"Designing Growth Strategies is in our DNA"

Fibrin Sealant Patch Market Size, Share & Industry Analysis, By Application (Gastrointestinal surgery, Trauma, Neurosurgery, Cardiovascular surgery, Others), By End-user (Hospitals, Specialty Clinics & Ambulatory Surgery Centres, Others) and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI101868 | Status : Ongoing

 

KEY MARKET INSIGHTS

In October 2016, Ethicon US, LLC. a subsidiary of Johnson & Johnson Services, Inc. announced that it received FDA approval for the company’s Evarrest fibrin sealant patch indicated to be used in a broad range of surgical procedures. The fibrin sealant patch is a two-component hemostatic patch, which contains, fibrinogen and thrombin derived from human plasma embedded in flexible composite patch either made of collagen or cellulose. Since the fibrin sealant patch brings both human fibrinogen and thrombin to the bleeding site, it does not rely on patient blood having adequate levels of fibrinogen to achieve hemostasis. A rising trend in the adoption of fibrin sealant patch is expected due to the various medical benefits of the innovative product offers. The fibrin sealant patches provide excellent enhancements in efficacy in surgery because they are easily combined with manual pressure to arrest bleeding. Additionally, the usability of the fibrin sealant patch has improved because they may be stored at room temperature and they two-component in packages ready for immediate use, and this is projected to increase the acceptance of the product during surgeries. Contrarily, liquid hemostatic products are more complex to prepare as it requires thawing, mixing and/or applicator loading.


Up Arrow

Key Market Driver -

Growing number of surgeries across the globe

Down Arrow

Key Market Restraint -

Risk of anaphylaxis and blood-borne disease transmission in addition to high cost of fibrin sealant patch


An increasing number of surgical procedures across the globe is expected to boost the global fibrin sealant patch market value during the forecast period. According to the America Hospital Association survey (2014), an estimated 17.2 million ambulatory hospital visits or inpatient stays required invasive, therapeutic surgery in the United States. Certain drawbacks of current hemostatic products which include limitations with efficacy and suboptimal ease-of-use are projected to increase the adoption of fibrin sealant patch in forthcoming years. One of the major advantages of fibrin sealant patch is that it can achieve hemostasis within 3-4 minutes of application.

Use of fibrin sealant causes anaphylactic reactions which may lead to further surgical complications. Reported cases of anaphylaxis which are caused due to the fibrin sealant patches are one of the factors expected to restrain the global fibrin sealant patch market growth during the forecast period. Additionally, the comparatively higher cost of fibrin sealant patch to that of traditional hemostatic products is projected to restrain the fibrin sealant market growth. High risk of transmission of viral and/or prion diseases due to the use of human pooled plasma in the fibrin sealant patch is expected to harm the growth of fibrin sealant patch.

Key Players Covered:


The major companies covered in the global fibrin sealant patch market report include Ethicon US, LLC.  Baxter and others.

As per the current fibrin sealant patch market trends, hospitals are holding the major share of the global fibrin sealant patch market due to the high requirement of hemostatic patches during surgeries.

Key Insights:



  • Overview of Regulatory Scenario For Key Countries

  • Key Industry Trends

  • Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018

  • Healthcare Overview – Number of Surgeries in Key Countries


Regional Analysis:


The global fibrin sealant patch market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold a dominating position in the fibrin sealant patch market share owing to highly developed healthcare infrastructure, accessibility of expertise and increasing awareness among the healthcare professionals regarding advantages of fibrin sealant patch. Additionally, the increasing requirement of cardiovascular surgeries and growing incidences of trauma cases in these regions are projected to be one of the major fibrin sealant market drivers.

To gain extensive insights into the market, Request for Customization


On the other hand, the countries of Europe are expected to follow the lead owing to increasing number of hospitalization, availably of trained healthcare professionals, combined with active government initiatives regarding healthcare infrastructure. Asia Pacific is projected to register comparatively higher CAGR owing to the higher patient pool experiencing cardiovascular and gastrointestinal medical indications. Countries of Latin America and Middle East and Africa captured a lower fibrin sealant market share owing to lower awareness regarding the product combined with the higher cost associated with the product compared to traditional hemostatic patches.

Segmentation






















 ATTRIBUTE

 DETAILS

By Application



  • Gastrointestinal surgery

  • Trauma

  • Neurosurgery

  • Cardiovascular surgery

  • Others



By End-user



  • Hospitals

  • Specialty Clinics & Ambulatory Surgery Centres

  • Others



By Geography



  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Fibrin Sealant Patch Industry Developments



  • In May 2019, Takeda Pharmaceutical Company Limited announced the divesture and sale of TachoSil to Ethicon US, LLC for US$ 400 Mn.

  • In April 2016, Takeda Pharmaceutical Company Limited announced the European Union approval of TachoSil extended indication in neurosurgery.

  • In March 2016, Ethicon US, LLC. announced that it has completed Phase III clinical trials of Evarrest fibrin sealant patch.





  • Ongoing
  • 2023
  • 2019-2022
  • Pre Book
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
Siemens Healthineers
Johnson
Fresenius
Ansell
Ipsos
Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X